Latest News
NESRO Hosts First CME Program of 2026 at Kathmandu Cancer Center
The Nepalese Society of Radiotherapy & Oncology (NESRO) successfully organized its first Continuing Medical Education (CME) program of 2026 on 23 January 2026 at the KCC Auditorium, Kathmandu Cancer Center (KCC).
NESRO Delegation Participates Meaningfully in FARO 2025
Kathmandu, Nepal — The Nepalese Society of Radiotherapy & Oncology (NESRO) is proud to announce the commendable performance and achievements of its delegates at FARO 2025 — the 7th meeting of Federation of Asian Organizations for Radiation Oncology (FARO), held from 13 to 15 November 2025 at The Empress Convention Center, Chiang Mai, Thailand.
Extended Committee NESRO
Executive committee: Dr Gisup Nikha Prasiko Dr Sandhya Chapagain Research Committee : Dr Ranjan Karmacharya Dr Simit Sapkota Committee of Leadership Development: Dr Subhas Pandit Dr Shweta Baral Education and Training Committee: Dr Bibek Acharya Dr Saugat Paudel Scientific Committee: Dr Surendra Gauchan Dr.
Workshop on Stereotactic Body Radiation Therapy (SBRT)
The Nepalese Society of Radiotherapy and Oncology (NESRO) recently conducted a comprehensive five-day workshop on Stereotactic Body Radiation Therapy (SBRT) from October 21-25, 2024.
Annual General Meeting of NESRO
The Nepal Society of Radiation Oncologists (NESRO) recently convened its Annual General Meeting (AGM) at Bhaktapur Cancer Hospital, marking a significant day for oncology professionals in the country.
CME on Cutaneous Cancers of Head and Neck
On August 10, 2024, a Continuing Medical Education (CME) program on Cutaneous Cancers of the Head and Neck was held at German Homes, Bhaktapur.
Use of AI advances adaptive radiotherapy for cancer care
Kill the cancerous tissue with radiation therapy and leave the healthy tissue untouched. Save the patient while sparing them as much as possible from treatment side effects.
Killing More Cancer Cells than Ever Before: A New Era in Radiotherapy
These advances can improve the quality of life for the patient during treatment. And for many types of cancer, improve targeting, reduce recurrence, and improve survival rates,” said May Abdel-Wahab, Director of the IAEA’s Human Health Division.
New Radiotherapy Technique for Treating Head and Neck Cancer Could Reduce Treatment Times by Nearly Half
More people with head and neck cancer in low- and middle-income countries (LMICs) may be able to access radiotherapy, after research carried out by the IAEA showed that fewer but higher doses of radiation treatment resulted in similar clinical outcomes to standard radiotherapy treatments.